Article Details

BioNTech and Bristol Myers Squibb Partner to Develop Bispecific Antibody Targeting PD-L1 ...

Retrieved on: 2025-06-15 02:00:04

Tags for this article:

Click the tags to see associated articles and topics

BioNTech and Bristol Myers Squibb Partner to Develop Bispecific Antibody Targeting PD-L1 .... View article details on hiswai:

Excerpt

BioNTech and Bristol Myers Squibb (BMS) have announced a collaboration to co-design and co-commercialize a new bispecific antibody candidate, ...

Article found on: www.geneonline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo